RxDoctor Payments Data

Dayna States

Family · Perkasie, PANPI 1235756230

Payments from drug & device makers

$1,927in general payments, 2019–2025

Across 105 payments — averaging $18.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$315
  • Novo Nordisk$228
  • Exact Sciences$190
  • Lilly USA, LLC$162
  • Astellas Pharma US Inc$128
  • Pfizer$125
  • plus $780 from 16 others

What the payments were for

  • Food & beverage$1,927100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,927 in reported general payments places this provider in the 80th percentile of 4,717 family providers in Pennsylvania.

See all family providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$50,072
Medicare patients
286
Services billed
859

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban12$11,952
Levothyroxine Sodium90$911
Simvastatin82$835
Atorvastatin Calcium83$833
Albuterol Sulfate HfaAlbuterol Sulfate43$742
Lisinopril84$693
Losartan Potassium58$656
Omeprazole31$527
Escitalopram Oxalate28$480
Sertraline Hcl50$419
Montelukast Sodium22$410
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide16$336
CefuroximeCefuroxime Axetil27$290
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst36$288
Metoprolol Succinate22$286

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$125$11,95212 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,717 family providers in Pennsylvania.

Other family in Perkasie

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →